Age of First Overweight and Obesity, COVID-19 and Long COVID in Two British Birth Cohorts.
Age of First Overweight and Obesity, COVID-19 and Long COVID in Two British Birth Cohorts.
复制标题
DOI:
10.1007/s44197-023-00093-5
复制
发表时间:
2023-03
影响因子:
7.3
通讯作者:
Silverwood, Richard J.
中科院分区:
文献类型:
--
作者:
Staatz, Charis Bridger;Bann, David;Ploubidis, George B.;Goodman, Alissa;Silverwood, Richard J.
Longer exposure to obesity, and thus a longer period in an inflamed state, may increase susceptibility to infectious diseases and worsen severity. Previous cross-sectional work finds higher BMI is related to worse COVID-19 outcomes, but less is known about associations with BMI across adulthood. To examine this, we used body mass index (BMI) collected through adulthood in the 1958 National Child Development Study (NCDS) and the 1970 British Cohort Study (BCS70). Participants were grouped by the age they were first overweight (> 25 kg/m2) and obese (> 30 kg/m2). Logistic regression was used to assess associations with COVID-19 (self-reported and serology-confirmed), severity (hospital admission and contact with health services) and long-COVID reported at ages 62 (NCDS) and 50 (BCS70). An earlier age of obesity and overweight, compared to those who never became obese or overweight, was associated with increased odds of adverse COVID-19 outcomes, but results were mixed and often underpowered. Those with early exposure to obesity were over twice as likely in NCDS (odds ratio (OR) 2.15, 95% confidence interval (CI) 1.17–4.00) and three times as likely in BCS70 (OR 3.01, 95% CI 1.74–5.22) to have long COVID. In NCDS they were also over four times as likely to be admitted to hospital (OR 4.69, 95% CI 1.64–13.39). Most associations were somewhat explained by contemporaneous BMI or reported health, diabetes or hypertension; however, the association with hospital admission in NCDS remained. An earlier age of obesity onset is related to COVID-19 outcomes in later life, providing evidence of the long-term impact of raised BMI on infectious disease outcomes in midlife. The online version contains supplementary material available at 10.1007/s44197-023-00093-5.
登录
查看更多内容
影响因子:
4.8
作者:
Khanijahani A;Iezadi S;Gholipour K;Azami-Aghdash S;Naghibi D
通讯作者:
Naghibi D
影响因子:
7.2
作者:
Mostafa, Tarek;Narayanan, Martina;Ploubidis, George B.
通讯作者:
Ploubidis, George B.
DOI:
10.1016/s2213-8587(21)00089-9
发表时间:
2021-06
期刊:
The lancet. Diabetes & endocrinology
影响因子:
--
作者:
Gao M;Piernas C;Astbury NM;Hippisley-Cox J;O'Rahilly S;Aveyard P;Jebb SA
通讯作者:
Jebb SA
影响因子:
3.7
作者:
Islam, Md Tauhidul;Moller, Jette;Liang, Yajun
通讯作者:
Liang, Yajun
DOI:
10.5114/aoms.2016.58928
发表时间:
2017-06
期刊:
Archives of medical science : AMS
影响因子:
--
作者:
Ellulu MS;Patimah I;Khaza'ai H;Rahmat A;Abed Y
通讯作者:
Abed Y